Search all trials

Find therapies in clinical trials near you – page 29

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Colorectal cancer metastatic

Not recruiting

Registered drugNo placebo

Study Comparing Relatlimab-Nivolumab Combination with Regorafenib or Trifluridine-Tipiracil for Patients with Advanced Metastatic Colorectal Cancer

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

Endometrial cancer

Not recruiting

Registered drugNo placebo

Study Comparing Pembrolizumab and Chemotherapy for Patients with Advanced or Recurrent Endometrial Cancer

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Type 1 diabetes mellitus

Not recruiting

Registered drug

Study on Frexalimab for Preserving Insulin Production in Newly Diagnosed Type 1 Diabetes Patients Aged 12-21 on Insulin Therapy

Registered drug

Sweden

Participants:0–17 years · 18–64 years

Contact Research Centre

Adenocarcinoma pancreas

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Autogene Cevumeran, Atezolizumab, and mFOLFIRINOX in Patients with Resected Pancreatic Cancer

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years

Contact Research Centre

Follicular lymphoma+1

Not recruiting

Registered drug

Study of Tafasitamab, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:Lenalidomide

Contact Research Centre

Retinitis pigmentosa

Not recruiting

InvestigationalNo placebo

Study on the Safety and Effects of CPK850 Gene Therapy for Patients with Retinitis Pigmentosa Due to RLBP1 Gene Mutations

InvestigationalNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Cpk850

Contact Research Centre

Neoplasm malignant+1

Not recruiting

InvestigationalNo placebo

Study on How Larotrectinib Works in Adults with Solid Tumors with NTRK Gene Fusion

InvestigationalNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Larotrectinib Sulfate

Contact Research Centre

Study on the Safety and Effectiveness of Epcoritamab with a Drug Combination for Patients with B-cell Non-Hodgkin Lymphoma

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Epcoritamab with a Drug Combination for Patients with B-cell Non-Hodgkin Lymphoma

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Anakinra

Contact Research Centre

Gastrointestinal stromal tumour

Not recruiting

Registered drugNo placebo

Study of CGT9486 and Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumors

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Sunitinib

Contact Research Centre

Breast cancer metastatic+1

Not recruiting

Registered drugNo placebo

Study on Imaging with 89Zr-Atezolizumab to Monitor Immune Responses in Patients with Metastatic Triple Negative Breast Cancer Using Atezolizumab and Drug Combination

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Autoimmune haemolytic anaemia+1

Not recruiting

Registered drugNo placebo

Study for Patients with Advanced Malignancies: Continued Treatment with Parsaclisib Alone or with Itacitinib, Ruxolitinib, Ibrutinib, or Tafasitamab

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Ibrutinib

Contact Research Centre

Pleural mesothelioma malignant

Not recruiting

Registered drugNo placebo

Study of Nivolumab, Ipilimumab, and UV1 Vaccine for Patients with Malignant Pleural Mesothelioma After Initial Chemotherapy

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Alrefimotide

Contact Research Centre

Find therapies in clinical trials near you – page 29

377 trials match your criteria

Colorectal cancer metastatic

Study Comparing Relatlimab-Nivolumab Combination with Regorafenib or Trifluridine-Tipiracil for Patients with Advanced Metastatic Colorectal Cancer

Endometrial cancer

Study Comparing Pembrolizumab and Chemotherapy for Patients with Advanced or Recurrent Endometrial Cancer

Type 1 diabetes mellitus

Study on Frexalimab for Preserving Insulin Production in Newly Diagnosed Type 1 Diabetes Patients Aged 12-21 on Insulin Therapy

Adenocarcinoma pancreas

Study on the Effectiveness and Safety of Autogene Cevumeran, Atezolizumab, and mFOLFIRINOX in Patients with Resected Pancreatic Cancer

Follicular lymphoma+1

Study of Tafasitamab, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

Retinitis pigmentosa

Study on the Safety and Effects of CPK850 Gene Therapy for Patients with Retinitis Pigmentosa Due to RLBP1 Gene Mutations

Neoplasm malignant+1

Study on How Larotrectinib Works in Adults with Solid Tumors with NTRK Gene Fusion

Study on the Safety and Effectiveness of Epcoritamab with a Drug Combination for Patients with B-cell Non-Hodgkin Lymphoma

Study on the Safety and Effectiveness of Epcoritamab with a Drug Combination for Patients with B-cell Non-Hodgkin Lymphoma

Gastrointestinal stromal tumour

Study of CGT9486 and Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumors

Breast cancer metastatic+1

Study on Imaging with 89Zr-Atezolizumab to Monitor Immune Responses in Patients with Metastatic Triple Negative Breast Cancer Using Atezolizumab and Drug Combination

Autoimmune haemolytic anaemia+1

Study for Patients with Advanced Malignancies: Continued Treatment with Parsaclisib Alone or with Itacitinib, Ruxolitinib, Ibrutinib, or Tafasitamab

Pleural mesothelioma malignant

Study of Nivolumab, Ipilimumab, and UV1 Vaccine for Patients with Malignant Pleural Mesothelioma After Initial Chemotherapy

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.